Over the last several years, our group has engineered microbial opsins, naturally occurring light-activated ion channels and pumps, for use in neuroscience, where they are in widespread use for assessing the causal contribution of a given cell type or pathway to neural circuit functions, behaviors, and pathologies. We have distributed these tools to perhaps thousands of labs, with often hundreds of requests before each publication appears. In this competing renewal R01 grant, we propose to extend this optogenetic toolbox in fundamentally new ways, in order to meet the challenges posed by outstanding sets of neuroscience questions.
First (Aim 1), we propose to develop a toolbox of optogenetic tools optimized for developmental neuroscience, including optogenetic silencers that are red-shifted enough (i.e., even into the infrared) and light-sensitive enough that they can support noninvasive optogenetic silencing (important because of the difficulty of using optical fibers in the size-changing developing mammalian brain), and opsins that can express extremely quickly (important because many opsins can take days to weeks to express, too long to be used to study development in many mammalian scenarios). These molecules will also have broad impact outside of developmental neuroscience: for example, the ability to noninvasively silence neurons will be useful for mammalian studies where brain lesion, aseptic compromise, glial activation, or inflammation from optical fiber insertion is undesired (e.g., in many disease studies), and in chronic experiments not compatible with long-term probe insertion.
Second (Aim 2), in order to optogenetically mimic endogenous ion channels and thus enable the causal testing of how specific ion conductances contribute to neural computation, we will use a novel automated microscopy methodology that we have developed, to perform a high-throughput screen for mutants that have more selective ion permeability, aiming to make light-driven potassium and sodium channels, which can mimic endogenous conductances in neurons. These molecules will enable the study, for example, of how specific conductances at specific points on neural dendrites or axons, contribute to the conversion of neural input into neural output.
Third (Aim 3), in order to understand how more complex neural activity patterns contribute to brain functions, we will enable optogenetics to be used to assess how multiple (e.g., >2) sets of neurons work together in a neural circuit, by improving the multiplexing capability of optogenetics to enable three different neuron classes to be independently controlled by three different colors of light. We will also enable clean two- photon activation of single cells embedded within intact brain networks, by restricting optogenetic protein expression just to cell bodies, so that attempts to stimulate single cells in densely labeled brain tissue do not artifactually stimulate nearby axons or dendrites passing by, or forming synapses upon cell bodies of interest. Finally (Aim 4), we will implement implantable waveguides equipped with active focusing and beam-steering, so that optogenetic control of neurons deep in the mammalian brain, with single cell resolution, is possible.

Public Health Relevance

The proposed research is relevant to public health because optogenetic tools for controlling the electrical activity of specific neuron types can reveal how they contribute to emergent brain functions, behaviors, and pathologies. Such an understanding will reveal many new clinical targets for treating brain disorders, e.g. pinpointing the sites in a circuit that, when targeted by a pharmacological agent or brain stimulator, lead to therapeutic benefit. Our technologies may also, in the future, serve directly as neural control therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA029639-07
Application #
9285766
Study Section
Special Emphasis Panel (ZRG1-ETTN-P (02)M)
Program Officer
Berton, Olivier Roland
Project Start
2010-07-01
Project End
2019-05-31
Budget Start
2017-06-01
Budget End
2018-05-31
Support Year
7
Fiscal Year
2017
Total Cost
$594,505
Indirect Cost
$121,949
Name
Massachusetts Institute of Technology
Department
Miscellaneous
Type
Other Domestic Higher Education
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Piatkevich, Kiryl D; Jung, Erica E; Straub, Christoph et al. (2018) A robotic multidimensional directed evolution approach applied to fluorescent voltage reporters. Nat Chem Biol 14:352-360
Oran, Daniel; Rodriques, Samuel G; Gao, Ruixuan et al. (2018) 3D nanofabrication by volumetric deposition and controlled shrinkage of patterned scaffolds. Science 362:1281-1285
Kolb, Ilya; Talei Franzesi, Giovanni; Wang, Michael et al. (2018) Evidence for Long-Timescale Patterns of Synaptic Inputs in CA1 of Awake Behaving Mice. J Neurosci 38:1821-1834
Piatkevich, Kiryl D; Suk, Ho-Jun; Kodandaramaiah, Suhasa B et al. (2017) Near-Infrared Fluorescent Proteins Engineered from Bacterial Phytochromes in Neuroimaging. Biophys J 113:2299-2309
Freifeld, Limor; Odstrcil, Iris; Förster, Dominique et al. (2017) Expansion microscopy of zebrafish for neuroscience and developmental biology studies. Proc Natl Acad Sci U S A 114:E10799-E10808
Chang, Jae-Byum; Chen, Fei; Yoon, Young-Gyu et al. (2017) Iterative expansion microscopy. Nat Methods 14:593-599
Barykina, Natalia V; Subach, Oksana M; Piatkevich, Kiryl D et al. (2017) Green fluorescent genetically encoded calcium indicator based on calmodulin/M13-peptide from fungi. PLoS One 12:e0183757
Shemesh, Or A; Tanese, Dimitrii; Zampini, Valeria et al. (2017) Temporally precise single-cell-resolution optogenetics. Nat Neurosci 20:1796-1806
Berry, Shaun; Redmond, Shawn; Robinson, Paul et al. (2017) Fluidic microoptics with adjustable focusing and beam steering for single cell optogenetics. Opt Express 25:16825-16839
Galvan, Adriana; Stauffer, William R; Acker, Leah et al. (2017) Nonhuman Primate Optogenetics: Recent Advances and Future Directions. J Neurosci 37:10894-10903

Showing the most recent 10 out of 33 publications